🇺🇸 FDA
Patent

US 10071977

Highly purifid pharmaceutical grade tasimelteon

granted A61PA61P25/20

Quick answer

US patent 10071977 (Highly purifid pharmaceutical grade tasimelteon) held by VANDA PHARMACEUTICALS INC. expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VANDA PHARMACEUTICALS INC.
Grant date
Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P25/20